BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 31572393)

  • 21. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
    Hung CY; Wozniak KL; Cole GT
    Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
    Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
    PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
    [No Abstract]   [Full Text] [Related]  

  • 23. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
    Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
    J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
    [No Abstract]   [Full Text] [Related]  

  • 24. Coccidioidomycosis in Northern Arizona: an Investigation of the Host, Pathogen, and Environment Using a Disease Triangle Approach.
    Mead HL; Kollath DR; Teixeira MM; Roe CC; Plude C; Nandurkar N; Donohoo C; O'Connor BLW; Terriquez J; Keim P; Barker BM
    mSphere; 2022 Oct; 7(5):e0035222. PubMed ID: 35972134
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coccidioidomycosis in the U.S. Military: a review.
    Crum-Cianflone NF
    Ann N Y Acad Sci; 2007 Sep; 1111():112-21. PubMed ID: 17435116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valley fever: danger lurking in a dust cloud.
    Johnson L; Gaab EM; Sanchez J; Bui PQ; Nobile CJ; Hoyer KK; Peterson MW; Ojcius DM
    Microbes Infect; 2014 Aug; 16(8):591-600. PubMed ID: 25038397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines against Coccidioides.
    Yoon HJ; Clemons KV
    Korean J Intern Med; 2013 Jul; 28(4):403-7. PubMed ID: 23864796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
    Kirkland TN; Raz E; Datta SK
    Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
    Fierer J; Waters C; Walls L
    J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
    Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
    Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis.
    Kollath DR; Miller KJ; Barker BM
    Virulence; 2019 Dec; 10(1):222-233. PubMed ID: 30898028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
    Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
    J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States.
    Jenks JD; Reed SL; Hoenigl M
    Mycoses; 2020 Jun; 63(6):553-557. PubMed ID: 32176829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Relationship Between Climate and Valley Fever (Coccidioidomycosis).
    Weaver EA; Kolivras KN
    Ecohealth; 2018 Dec; 15(4):840-852. PubMed ID: 30284073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Population Genetics to Assess the Ecology, Evolution, and Population Structure of Coccidioides.
    Teixeira MM; Barker BM
    Emerg Infect Dis; 2016 Jun; 22(6):1022-30. PubMed ID: 27191589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
    Hung CY; Castro-Lopez N; Cole GT
    Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
    Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
    J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.